China Galaxy Securities First Quarter 2025 Earnings: EPS: CN¥0.25 (vs CN¥0.12 in 1Q 2024)

Simply Wall St

China Galaxy Securities (HKG:6881) First Quarter 2025 Results

Key Financial Results

  • Revenue: CN¥7.55b (up 4.7% from 1Q 2024).
  • Net income: CN¥3.02b (up 85% from 1Q 2024).
  • Profit margin: 40% (up from 23% in 1Q 2024). The increase in margin was primarily driven by lower expenses.
  • EPS: CN¥0.25 (up from CN¥0.12 in 1Q 2024).
SEHK:6881 Earnings and Revenue Growth May 1st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

China Galaxy Securities Earnings Insights

Looking ahead, revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Capital Markets industry in Hong Kong.

Performance of the Hong Kong Capital Markets industry.

The company's shares are down 1.9% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with China Galaxy Securities (at least 1 which makes us a bit uncomfortable), and understanding these should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if China Galaxy Securities might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.